A
AEON Biopharma, Inc. (AEON)
ASE – Real vaqt narxi. Valyuta: USD
0.72
+0.03 (4.62%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.70
-0.02 (-2.47%)
Bozordan keyin: Jun 26, 2026, 7:36 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
ASE – Real vaqt narxi. Valyuta: USD
0.72
+0.03 (4.62%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.70
-0.02 (-2.47%)
Bozordan keyin: Jun 26, 2026, 7:36 PM EDT
AEON Biopharma, Inc., klinik tadqiqot bosqichidagi biofarmatsevtika kompaniyasi, botulinum toksinlarini ishlab chiqishga qaratilgan. U og'ir tibbiy sharoitlar uchun ABP-450 (prabotulinumtoxinA) in'ektsiyasini ishlab chiqadi, bu servikal distoniya davolash uchun 2-bosqich tadqiqotini yakunlagan va surunkali va epizodik migrenni davolash uchun 2-bosqich tadqiqotini olib bormoqda. Kompaniya, shuningdek, ABP-450ni gastroparez va post-travmatik stress buzilishini davolash uchun ishlab chiqadi. Kompaniya Daewoong Pharmaceutical Co., LTD. va Viatris Inc. bilan litsenzion shartnomalarga ega. Kompaniya Kaliforniyaning Irvayn shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Chad K. Oh M.D. | Chief Medical Officer |
| Mr. Alex Wilson | Chief Legal & Strategy Officer and Corporate Secretary |
| Mr. John A. Bencich M.B.A. | Chief Financial Officer |
| Mr. Robert Bancroft | President, CEO & Director |
| Ms. Jennifer Sy | Chief Accounting Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-17 | 8-K | aeon-20260617x8k.htm |
| 2026-05-14 | 8-K | aeon-20260514x8k.htm |
| 2026-04-29 | DEFA14A | aeon-20231109xdefa14a.htm |
| 2026-04-29 | DEF 14A | aeon-20260429xdef14a.htm |
| 2026-04-03 | 8-K | aeon-20260331x8k.htm |
| 2026-03-31 | S-8 | aeon-20231109xs8.htm |
| 2026-03-30 | 8-K | aeon-20260330x8k.htm |
| 2026-03-30 | 10-K | aeon-20251231x10k.htm |
| 2026-03-09 | 8-K | aeon-20260306x8k.htm |
| 2026-02-12 | CORRESP | filename1.htm |